Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026)
Labcorp Holdings (LH) posted Cash from Financing Activities of $580.5 million for Q1 2026, up 299.9% sequentially from -$290.4 million in Q4 2025, and up 169.13% YoY from $215.7 million in Q1 2025.
Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Labcorp Holdings has reported Cash from Financing Activities for 18 years, with the latest figure at $580.5 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 169.13% year-over-year to $580.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.8 million (up 23.49% YoY) and the FY2025 annual result came in at -$1.5 billion, down 286.82% from the prior year.
- Cash from Financing Activities grew to $580.5 million in Q1 2026 per LH's latest filing, from -$290.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.5 billion in Q3 2024 and troughed at -$1.1 billion in Q3 2023.
- A 5-year average of -$86.9 million and a median of -$267.4 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 422.08% in 2023, then tumbled 7076.92% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$372.6 million in 2022, then retreated by 19.83% to -$446.5 million in 2023, then decreased by 22.44% to -$546.7 million in 2024, then soared by 46.88% to -$290.4 million in 2025, then soared by 299.9% to $580.5 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $580.5 million, -$290.4 million, and -$59.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 580.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 580.50 Mn |
| Mar 31, 2026 | 580.50 Mn |
| Dec 31, 2025 | -290.40 Mn |
| Dec 31, 2025 | -290.40 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -267.40 Mn |
| Jun 30, 2025 | -267.40 Mn |
| Mar 31, 2025 | -839.70 Mn |
| Mar 31, 2025 | -839.70 Mn |
| Dec 31, 2024 | -546.70 Mn |
| Dec 31, 2024 | -546.70 Mn |
| Sep 30, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | -210.00 Mn |
| Jun 30, 2024 | -210.00 Mn |
| Mar 31, 2024 | -11.70 Mn |
| Mar 31, 2024 | -11.70 Mn |
| Dec 31, 2023 | -446.50 Mn |
| Dec 31, 2023 | -446.50 Mn |